122 related articles for article (PubMed ID: 2462981)
21. [Application of the 2-mercaptoethanol test to the diagnosis and prediction of hemolytic disease of the newborn due to ABO incompatibility].
Buñuel C; Lucia JF; Raichs A
Sangre (Barc); 1973; 18(1):15-20. PubMed ID: 4708548
[No Abstract] [Full Text] [Related]
22. Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn.
Bromilow IM; Duguid JK
Br J Haematol; 1991 Aug; 78(4):588. PubMed ID: 1911360
[No Abstract] [Full Text] [Related]
23. [Diagnosis of hemolytic disease of the newborn on the basis of an hr' (c)-conflict].
Dobronravov AV; Zinger TI
Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):55. PubMed ID: 1273066
[No Abstract] [Full Text] [Related]
24. [Hemolytic disease of the newborn. Current aspects].
Colasson F; Astoul AM
Servir; 1984; 32(5):278-81. PubMed ID: 6443324
[No Abstract] [Full Text] [Related]
25. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes.
Branch DR; Gallagher MT; Mison AP; Sy Siok Hian AL; Petz LD
Br J Haematol; 1984 Jan; 56(1):19-29. PubMed ID: 6704325
[TBL] [Abstract][Full Text] [Related]
26. Editorial: Management of maternal isoimmunization.
Med J Aust; 1974 Oct; 2(15):547-8. PubMed ID: 4214982
[No Abstract] [Full Text] [Related]
27. [Diagnostic and prognostic significance of changes in adenosintriphosphatase activity of erythrocytes in hemolytic disease of the newborn].
Osinov AI
Vopr Okhr Materin Det; 1966 Feb; 11(2):19-23. PubMed ID: 4226874
[No Abstract] [Full Text] [Related]
28. Coordinating Care Across the Perinatal Continuum in Hemolytic Disease of the Fetus and Newborn: The Timely Handoff of a Positive Maternal Anti-Erythrocyte Antibody Screen.
Vats K; Watchko JF
J Pediatr; 2019 Nov; 214():212-216. PubMed ID: 31451186
[No Abstract] [Full Text] [Related]
29. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
Gurevich P; Erina S; Gershon S; Zusman I
Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
[TBL] [Abstract][Full Text] [Related]
30. [Anti-M antibodies in the pathogenesis of hemolytic disease of the newborn].
Lenkiewicz B; Kuśnierz-Alejska G; Lukowska J; Klimaszewska A
Acta Haematol Pol; 1989; 20(2):229-34. PubMed ID: 2638542
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of hemolysis.
Zipursky A
Mead Johnson Symp Perinat Dev Med; 1982; (19):17-24. PubMed ID: 6821465
[TBL] [Abstract][Full Text] [Related]
32. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
[TBL] [Abstract][Full Text] [Related]
33. The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay.
Schanfield MS; Stevens JO; Bauman D
Transfusion; 1981; 21(5):571-6. PubMed ID: 6794195
[TBL] [Abstract][Full Text] [Related]
34. [Perinatal hemolytic disease caused by anti-c. A clinical case].
Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
[No Abstract] [Full Text] [Related]
35. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
36. [Problems of ABO hemolytic disease in the newborn infant].
Novachev D; Markov L
Akush Ginekol (Sofiia); 1980; 19(3):253-7. PubMed ID: 6992621
[No Abstract] [Full Text] [Related]
37. [Current status of the serology of the erythrocyte series].
Martín Vega C
Sangre (Barc); 1984; 29(4-C):651-5. PubMed ID: 6393387
[No Abstract] [Full Text] [Related]
38. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
Monestier M; Rigal D; Juron-Dupraz F; Meyer F
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
[TBL] [Abstract][Full Text] [Related]
39. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother.
Wang M; Hays T; Ambruso DR; Silliman CC; Dickey WC
Pediatr Blood Cancer; 2005 Nov; 45(6):861-2. PubMed ID: 16007582
[No Abstract] [Full Text] [Related]
40. [Rhesus erythroblastosis, monitoring and treatment].
Siebers JW; Rasenack R; Hillemanns HG
Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
